Health plan trustees at a Minneapolis-based construction workers union are suing a subsidiary of UnitedHealth Group for ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...

In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Ticker: Wegovy and Zepbound prices fall; ExxonMobil and partner Qatar Energy find new natural gas deposit off Cyprus ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...